EUVIMEDEUVIMED entdecken
Crossref

Cysteine protease inhibitor S promotes lymph node metastasis of esophageal cancer cells via VEGF-MAPK/ERK-MMP9/2 pathway

Jiayi Guo, Zhengyu Song, AlimuJiang Muming, Haiping Zhang, Edris Awut

Naunyn-Schmiedeberg's Archives of Pharmacology · 2024

DOI: 10.1007/s00210-024-03014-w ↗

Kurz gefasst

Fachartikel in der Zeitschrift Naunyn-Schmiedeberg's Archives of Pharmacology, 2024. Verfasst von Jiayi Guo und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Thoracic Surgery, The First Affiliated Hospital of Xinjiang Medical University, No. 393 Xinyi Road, Urumqi, 830054, Xinjiang, China. Hauptthemen laut MEDLINE: Esophageal Neoplasms, Lymphatic Metastasis, Matrix Metalloproteinase 9, Cell Proliferation. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 30 Literaturangaben. Gefördert von: the National Natural Science Foundation of China, open Project of State Key Laboratory of Causes and Prevention of High Incidence in Central Asia Co-constructed by Province and Ministry.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Esophageal NeoplasmsLymphatic MetastasisMatrix Metalloproteinase 9Cell ProliferationCell MovementEpithelial-Mesenchymal TransitionMatrix Metalloproteinase 2Vascular Endothelial Growth Factor AHumansCell Line, TumorMAP Kinase Signaling SystemLymphangiogenesisApoptosisSignal Transduction

Stichwörter der Autor:innen

CST4Esophageal cancerHLECsLymphangiogenesis

Substanzen

Matrix Metalloproteinase 9Matrix Metalloproteinase 2Vascular Endothelial Growth Factor AMMP9 protein, humanMMP2 protein, humanVEGFA protein, human

Autor:innen und Institutionen

  • Department of Thoracic Surgery, The First Affiliated Hospital of Xinjiang Medical University, No. 393 Xinyi Road, Urumqi, 830054, Xinjiang, China.
  • The First Clinical Medical College, Xinjiang Medical University, Urumqi, 830054, China.
  • Department of Thoracic Surgery, The First Affiliated Hospital of Xinjiang Medical University, No. 393 Xinyi Road, Urumqi, 830054, Xinjiang, China. docedrs@163.com.
  • The First Clinical Medical College, Xinjiang Medical University, Urumqi, 830054, China. docedrs@163.com.

Förderung

  • the National Natural Science Foundation of China
  • open Project of State Key Laboratory of Causes and Prevention of High Incidence in Central Asia Co-constructed by Province and Ministry

Zitieren

APA

Guo, J., Song, Z., Muming, A., Zhang, H., & Awut, E. (2024). Cysteine protease inhibitor S promotes lymph node metastasis of esophageal cancer cells via VEGF-MAPK/ERK-MMP9/2 pathway. Naunyn-Schmiedeberg's Archives of Pharmacology. https://doi.org/10.1007/s00210-024-03014-w

Vancouver

Guo J, Song Z, Muming A, Zhang H, Awut E. Cysteine protease inhibitor S promotes lymph node metastasis of esophageal cancer cells via VEGF-MAPK/ERK-MMP9/2 pathway. Naunyn-Schmiedeberg's Archives of Pharmacology. 2024. doi:10.1007/s00210-024-03014-w

BibTeX
@article{Guo2024,
  author = {Guo, Jiayi and Song, Zhengyu and Muming, AlimuJiang and Zhang, Haiping and Awut, Edris},
  title = {Cysteine protease inhibitor S promotes lymph node metastasis of esophageal cancer cells via VEGF-MAPK/ERK-MMP9/2 pathway},
  journal = {Naunyn-Schmiedeberg's Archives of Pharmacology},
  year = {2024},
  doi = {10.1007/s00210-024-03014-w}
}
Kostenlos starten →